North-East Healthcare Investment

North-East Healthcare Investment is a Swiss-based private investment firm that serves as the investment vehicle for the North-East Family Office, focusing on direct investments in healthcare-related companies. The firm's investment mandate encompasses a broad interpretation of healthcare, with a particular emphasis on med-tech and diagnostic opportunities that have a proven regulatory path and are profitable or close to profitability. This includes investments across all stages, from start-ups and spin-offs to mature companies. The firm collaborates with experienced executives, entrepreneurs, and other dedicated investors to facilitate these investments.

The company's portfolio includes Reapplix, a Danish biotech company specializing in advanced wound care solutions. Reapplix exemplifies North-East Healthcare Investment's commitment to supporting innovative healthcare solutions that address significant medical needs. The firm's strategic focus on med-tech and diagnostics aligns with its goal of advancing healthcare through investments in companies with proven regulatory paths and strong growth potential.

North-East Healthcare Investment's approach reflects a dedication to fostering innovation in the healthcare sector by providing capital and expertise to companies poised for success. By partnering with experienced professionals and other investors, the firm aims to drive growth and deliver impactful healthcare solutions to the market.